Abstract
The present study evaluated the effects of a commercial soy lecithin-containing bioemulsifier Lysomax® on growth performance, feed utilization, haematology, immune response and gut histology of adult Nile tilapia (Oreochromis niloticus) fed soybean meal-based diets, containing plant oil as a lipid source. This emulsifier was incorporated into four isonitrogenous (30% cp), isocaloric (17.5 MJ/kg) test diets, at 0 (control), 0.3, 0.6 and 0.9 g/kg feed. The diets were fed to triplicate groups of adult Nile tilapia, reared in a closed recirculating indoor system, at a daily rate of 3% of fish live weight, twice a day for 60 days. Growth rates, feed utilization efficiency, digestive enzymes activities, blood parameters, liver function enzymes and immunological responses were all boosted (p < .05) with increasing supplemental Lysomax up to 0.3 g/kg diet, followed by a significant retardation (p < .05) at 0.6 and 0.9 levels. Muscle n-6 and n-3 polyunsaturated fatty acids (PUFA) and n3/n6 ratio were also increased with increasing Lysomax up to 0.3 level and then levelled off with further increase in dietary Lysomax. The highest length and width of the intestinal microvilli and goblet cell counts were also found in the fish fed on 0.3 g Lysomax/kg diet. However, the quadratic regression analyses of the obtained results indicated that the maximum performance occurred at about 0.45 g/kg of dietary Lysomax. These results suggest that lecithin-containing bioemulsifier Lysomax® can play a significant role in feed digestion and absorption and improving fish performance and innate immune response. About 0.45 g/kg diet would be sufficient for best performance and health status of farmed Nile tilapia.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.